Application and Generalization of Flutter Mucus Clearance Device

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

356 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Respiratory Mechanics Effects of Flutter Valve in Bronchiectasis Patients

NCT00656721

Bronchiectasis

COMPLETED NA

Inspiratory Muscle Training in Individuals With Cystic Fibrosis

NCT03737630

Cystic Fibrosis

COMPLETED NA

Selective Manual Therapy Techniques in Chronic Obstructive Pulmonary Disease

NCT05781867

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Inspiratory Muscle Training in HFpEF

NCT06510231

Heart Failure

RECRUITING NA

Effects of Home-based Inspiratory Muscle Training in Patients With IPF

NCT05353556

Idiopathic Pulmonary Fibrosis IPF

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Respiratory diseases are still increasing in elder population. Sputum detaining is a common contributing factor to acute exacerbation. The fluttering mucus clearance technique is expected to be a physical assisting therapy enhancing airway secretion clearance but need more clinical randomized control trial evidence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

flutter mucus clearance device

Group Type EXPERIMENTAL

flutter mucus clearance device

Intervention Type DEVICE

five minutes every session, four sessions per day

2

Observation

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

flutter mucus clearance device

five minutes every session, four sessions per day

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pulmonary department: available to perform the device, in-hospital patients

* Male and female
* Age: 45 - 85 years
* Chronic bronchitis, COPD
* Thoracic surgery department and surgical department (upper abdomen):

* Patients with endotracheal intubation of general anesthesia
* Age: 40-75 years

Exclusion Criteria

* Not available to perform the procedure
* Untreated pneumothorax
* Diffusion interstitial lung disease
* Acute coronary syndrome
* Third stage hypertension
* Advanced cancer
* Severe heart, liver, renal , blood system and endocrine system dysfunction
* Noninvasive mechanical ventilation more than 6 hrs per day
* Patients with invasive ventilation and cannot weaning and extubation within 48 hours
* Active hemoptysis

Minimum Eligible Age

40 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No